Federal Register Final rule: FDA is amending the animal drug regulations to reflect approval of a Pfizer supplemental NADA that adds a pathogen, Mycoplasma bovis, to the indication for use of tulathromycin, by injection, for controlling respiratory disease in high-risk cattle. To view this final rule, click here.
